Searching for antiparasitics with a different mode of action than existing drugs, and (or) with the same but much more effective mechanisms is necessary to periodically update the applicable protection chemicals. For the first time we here present data on the biocidal action of new semisynthetic derivatives of avermectin B1 that we have synthetized earlier. These are the 16-membered macrocyclic lactones, the representatives of an important class of anthelmintics. In 2015 S. Omura (Japan) and W. Campbell (USA) who discovered this avermectin group, were awarded the Nobel Prize in physiology and medicine. In our study the oligochaetes Tubificidal tubifex were used as a test-object. The original chemicals and synthetized derivatives tested were avermectin B1 
macrocyclic lactones [1] , especially 16-membered macrocyclic lactones with a broad spectrum of the antiparasitic activity. Adaptation of parasites (the development of resistance) to the applied aagents, and focus on high-performance and environmentally safer remedies promote the search for substances with both a novel mechanism of antiparasitic action and a known, but more effective one [2] .
The 16-membered macrocyclic lactones (avermectins and other, similar in structure, natural macrolides called milbemycins or their semi-synthetic analogues) are widely used to control parasites (nematodes, insects and mites) in humans, animals and plants. For the discoveries of a novel avermectin-based therapy of infections caused by roundworm parasites, S. Оmura (Japan) and W. Campbell (USA) were awarded 2015 Nobel Prize in Physiology or Medicine [3] .
Evolution of pharmaceutical substances based on macrocyclic lactones suggests in particular the chemical modification of the natural metabolites and derivation of analogues that are the most suitable for practical purposes ( Fig.  1 ) [4] [5] [6] [7] [8] . Various avermectins and related milbemycin-based substances have been introduced in the medical, veterinary and agronomic practices, such as a mixture of avermectin B1a and B1b (abamectin, 1979), ivermectin (1981), doramectin (1993), avermectin B1 benzoate (1997), eprinomectin (1997), and selamectin (2000), as well as close to them Milbemectin, a mixture of A3 (a3) and A4 (a4) milbemycins (1990), lepimectin (a derivative of milbemectin, 2004), a derivative of nemadectin (Moxidectin, 1989) , and Gemax [2, 4] . Antiparasitic action of all these macrolides is due to the pharmacophore group, i.e. a unique 16-membered lactone [2] , specifically interacting with glutamate- [9] and GAB A -dependent Cl  -ion channels [10] . Most studies on the mechanism of avermectins' action, i.e. membrane hyperpolarization resulted from activation of glutamate-and GABA A -dependent channels, were made with ivermectin, as the most frequent in practice [11] [12] [13] [14] . In general, findings of such studies are applicable to all members of this class, although lactones are not similar in structure, and their effect may vary [15] [16] [17] .
In the present study, we first report biocidal action of new semisynthetic avermectin B1 derivatives on oligochaetes. These findings allowed to select several promising compounds, such as 5-O-succinyl avermectin B1, 5-O-ethylsuccinyl avermectin B1 and 5,4-di-O-ethylsuccinyl avermectin B1. A decrease in toxicity (LD 50 of 37.85, 41.37 and 45.82 mg/kg, respectively) was revealed compared to avermectin B1 (15-20 mg/kg) [18] . We compared avermectin B1, ivermectin and 5-O-succinyl avermectin B1 interaction with GABA A -receptors, which are a biotarget for this class of compounds, using rat brain membrane preparations as a model for in vitro screening and evaluation of natural and semi-synthetic avermectins. It was revealed that maximal inhibition of specific binding for these synthesized derivatives, estimated by radioligand binding assay, increased.
The aim of this work was to study biocidal properties of the semi-synthetic derivatives of 16-membered macrocyclic lactones and their interaction with the GABA A -receptors.
Technique. The 5-O-and 5,4-di-O-derivatives of avermectin B1, ivermectin, and monosaccharide analogues have been previously synthesized [2, 19] . Their antiparasitic activity at a dose of 15 g/ml was studied in a rapid assay using Tubifex tubifex oligochaetes. Acute toxicity of 5-O-succinyl-, 5-Oethylsuccinyl-, 5,4-di-O-ethylsuccinyl avermectins B1 was determined according to the recommendations on preclinical studies of drugs using white outbred mice weighing 18-21 g (the drug was administered intraperitoneally) [20] .
For the radioreceptor assay, avermectin B1, ivermectin and a hemisuccinate derivative of avermectin B1 were dissolved in dimethylsulfoxide (DMSO). In vitro effects of the substances on the GABA A -receptors were investigated at the range of concentrations of 10 -10 -10 -4 mol/l.
Membrane preparations containing GABA A -receptors of rat cerebral cortex were isolated by a modified method of J.E. Hawkinsonet al. [21] . Biomaterial was taken after decapitation. Frontal cortex was separated and homogenized (a Potter S homogenizer, Sartorius AG, Germany) in 20 volumes of ice-cold sucrose (0.32 M, pH 7.1). A dense fraction was separated using the Optima L-70K ultracentrifuge (Beckman Coulter, Inc., USA) for 10 min at 1 000 g. The supernatant was re-centrifuged (20 000 g, 20 min). The precipitate was resuspended in 20 ml of cold distilled water and centrifuged (8 000 g, 20 min), the supernatant and the yellow supernatant were centrifuged once again at 48 000 g for 20 min. The precipitate was suspended in a freshly prepared 0.05M Tris-citrate buffer (TCB) (pH 7.1) and centrifuged (48 000 g, 20 min). The resulting membrane fraction was frozen and stored at 85 С. On the day of testing, the membranes were suspended in 40 volumes of 0.05M TCB (pH 7.1) and centrifuged at 48 000 g for 20 min. The resulting precipitate was suspended in 40 volumes of 0.05M TCB (pH 7.1), incubated at 24 С for 30 min, and centrifuged again at 48 000 g for 20 min. The final precipitate was resuspended in the fresh buffer.
Tritium-labeled [G-3 H]SR 95531 (Perkin Elmer, USA) with a specific activity of 49.5 Ci/mmol was used in radioligand binding assays. The incubation mixture (0.5 ml final volume) contained 50 l of [G-3 H]SR 5531, 250 l of buffer and 200 l of membrane protein suspension; for non-specific binding, 50 l of unlabeled SR 95531 ligand (1 mM) was added. The reaction mixture was incubated at 4 С for 1 hour. After incubation samples were passed through the GF/B glass fiber filters (Whatman PLC, UK) previously immersed in 0.3 % polyethylenimine for 2 hours. Each tube was washed twice with cold buffer and then the filters were washed twice with the same volume of buffer. The filters were dried out in air, transferred to scintillation vials and poured over with 5 ml of scintillation liquid (4 g of PPO, 0.2 g of POPOP per liter of toluene). Radioactivity was determined on a Tri-Carb 2900TR counter (Perkin Elmer, USA) with 42-46 % counting efficiency . Specific binding was calculated as the difference between total and non-specific binding. The results of radioligand binding assay were expressed as the concentration corresponding to 50 % inhibition of specific radioligand binding (IC 50 ) and the maximal degree of inhibition (I max ), reflecting the difference between the lower and upper plateau [21] . Protein concentration was measured by a standard procedure [22] .
Animal experiments were performed in accordance with the provisions of the Geneva Convention and the principles of Good Laboratory Practice (National Standard of the Russian Federation, GOST R 53434-2009), as well as recommendations set out in The Guide for the Care and Use of Laboratory Animals (Na-tional Academy Press Washington, DC 1996).
GraphPad Prizm 4 Demo (https://www.graphpad.com, GraphPad Software, Inc., USA) was used to process binding displacement curves. Statistical processing was performed using Statistica 6 software package (http://www.statsoft.ru, Statsoft Inc., USA). The arithmetic mean (m) and standard error of the mean (SEM) are given, the significance of differences was assessed by the Student's t-test at p < 0.05.
Results. We examined the biological effects of the synthesized 5-O-and 5-O-4-O-derivatives as well as ivermectin and a number of monosaccharide analogues derived previously (Table 1 ). Antiparasitic activity parameters of the compounds we selected (see Table 1 ) evidenced a strong biocidal action: after a 30-minute exposure of oligochaetes to the 1.5 % isopropanol solution of the tested compounds (15 g/ml), half of the specimens lost their motor activity (see Table 1 ). Three of the tested compounds (5-O-succinyl-, 5-O-ethylsuccinyl-and 5,4-di-O-succinyl avermectin B1) were selected for the acute toxicity evaluation.
LD 50 of 5-O-succinyl avermectin B1 for mice was 37.85 mg/kg, and LD 100 was 70.35 mg/kg, while of 5-O-succinyl avermectin B1 these were 41.37 and 74.27 mg/kg, respectively, and of 5,4-di-O-ethylsuccinyl avermectin B1 -45.82 and 78.23 mg/kg, respectively. These values are comparable to LD 50 for currently used avermectin-based products, such as 20 and 30 mg/kg for abamectin and ivermectin [18] .
The clinical manifestations of the toxic effects of the compounds were similar (muscle tremors, convulsions). All animals demonstrated discoordination of movements followed by strong depression: mice were lying, reactions to external stimuli were absent, and the death occurred within 20-30 min. Autopsy of the dead mice and the animals sacrificed at the end of the experiments showed no visible pathological changes. Therefore, according to the regulations of the State Standard GOST 12.1.007-76, these compounds can be regarded as substances of toxicity class II.
In vitro study of the influence on GABA A -receptors showed that unlabeled SR 95531, the bromic 2-(3-carboxy prolyl)-3-amino-6-(4-methoxyphenyl)pyridazine (i.e. gabazine, a competitive antagonist of GABA A -receptors), almost completely replaced [G- 3 (Fig. 2, Table 2 ). A hemisuccinate of avermectin B1, i.e. an original derivative of avermectin B1, and ivermectin were shown to be more active inhibitors. Their I max increased by one third (up to 35.9±1.4 and 33.5±1.4 %, respectively; p < 0.05). However, all three studied substances had similar IC 50 values in the micromolar range ( Table 2) .
The results suggest that chemical modification of the avermectin B1 molecule significantly increased the competitive activity of the original compound, i.e. 5-O-succinyl avermectin, for the binding sites of [G-3 H]SR 95531 with GA-BA A -receptors. The use of labelled antibodies against GABA in the experiments with nematodes showed that 26 of 302 neurons in Caenorhabditis elegans were GABA-ergic [23] , and genetic screening allowed to identify six genes which are required to perform the neural functions of GABA [24] .
It is assumed that all three avermectins act as allosteric modulators of a specific GABA A -receptor competitive ligand SR 95531 (gabazine) [25] . This is a GABA-derivative of arilaminopyridazine, which is a competitive receptor antagonist in mammals, whereas in invertebrates the substance SR 95103, i.e. 2-(3-carboxy prolyl)-3-amino-4-methyl-6-phenylpyridazine, is more active [26] . Recent investigations in several laboratories have shown that the primary targets for macrocyclic lactones are glutamate-dependent chloride channels [4, 27] . These channels are not detected in mammals, but belong to the so-called family of Cys-loop channel receptors that includes GABA-, glycine, nicotine and serotonin-3 receptors. This, in particular, allowed using GABA A -receptor of rat brain as a model to screen and study the mechanism of action of natural and semisynthetic avermectins.
Thus, the study of the biocidal action of a number of 5-O-substituted avermectins found that the 1.5 % solution of 5-O-succinyl, 5-O-ethylsuccinyl and 5,4-di-O-ethylsuccinyl avermectin B1 after a 60-minute exposure completely paralyzed oligochaetes. The LD 50 values of these compounds, when administered intraperitoneally to mice at a dose of 37-47 mg/kg, are comparable to or lower than those of the known analogues. Moreover, based on the effects according to State Standard GOST 12.1.007-76, these substances belong to toxicity class II, i.e. can be considered as promising antiparasitic agents.
